Skip to content
← Full study record

NCT01047345 · FLOW

Participant flow

A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) · Source last updated 2018-11-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Blinded 9vHPV vaccine (V503) 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Base Study. Participants will not continue to the Extension Study.
    id
    FG000
    title
    9vHPV Vaccine - Base Study
  2. description
    Blinded 0.5 mL intramuscular injection of saline placebo at Day 1, Month 2, and Month 6 of the Base Study. After completion of the Base Study, participants will be eligible to receive open-label 9vHPV 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Extension Study.
    id
    FG001
    title
    Placebo - Base Study
  3. description
    Participants who received placebo in Base Study and elected to have open-label 9vHPV vaccination in Extension Study.
    id
    FG002
    title
    9vHPV Vaccine - Extension Study
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Protocol Violation
    4. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        0
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        618
      2. group Id
        FG001
        num Subjects
        306
      3. group Id
        FG002
        num Subjects
        0
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        615
      2. group Id
        FG001
        num Subjects
        306
      3. group Id
        FG002
        num Subjects
        0
      type
      Vaccination 1
    3. achievements
      1. group Id
        FG000
        num Subjects
        604
      2. group Id
        FG001
        num Subjects
        304
      3. group Id
        FG002
        num Subjects
        0
      type
      Vaccination 2
    4. achievements
      1. group Id
        FG000
        num Subjects
        597
      2. group Id
        FG001
        num Subjects
        300
      3. group Id
        FG002
        num Subjects
        0
      type
      Vaccination 3
    5. achievements
      1. comment
        Includes 1 participant for whom completion status is unknown
        group Id
        FG000
        num Subjects
        596
      2. group Id
        FG001
        num Subjects
        300
      3. group Id
        FG002
        num Subjects
        0
      type
      COMPLETED
    6. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        6
      3. group Id
        FG002
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Base Study
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Withdrawal by Subject
    2. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        5
      type
      Lost to Follow-up
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. comment
        Not all eligible participants elected to participate in extension
        group Id
        FG002
        num Subjects
        102
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        102
      type
      Vaccination 4
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        99
      type
      Vaccination 5
    4. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. comment
        1 participant received 6th vaccination outside the context of study but completed the study.
        group Id
        FG002
        num Subjects
        95
      type
      Vaccination 6
    5. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        96
      type
      COMPLETED
    6. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        6
      type
      NOT COMPLETED
    title
    Extension
Complete source fields
groups
  1. description
    Blinded 9vHPV vaccine (V503) 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Base Study. Participants will not continue to the Extension Study.
    id
    FG000
    title
    9vHPV Vaccine - Base Study
  2. description
    Blinded 0.5 mL intramuscular injection of saline placebo at Day 1, Month 2, and Month 6 of the Base Study. After completion of the Base Study, participants will be eligible to receive open-label 9vHPV 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 of the Extension Study.
    id
    FG001
    title
    Placebo - Base Study
  3. description
    Participants who received placebo in Base Study and elected to have open-label 9vHPV vaccination in Extension Study.
    id
    FG002
    title
    9vHPV Vaccine - Extension Study
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Protocol Violation
    4. reasons
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        0
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        618
      2. group Id
        FG001
        num Subjects
        306
      3. group Id
        FG002
        num Subjects
        0
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        615
      2. group Id
        FG001
        num Subjects
        306
      3. group Id
        FG002
        num Subjects
        0
      type
      Vaccination 1
    3. achievements
      1. group Id
        FG000
        num Subjects
        604
      2. group Id
        FG001
        num Subjects
        304
      3. group Id
        FG002
        num Subjects
        0
      type
      Vaccination 2
    4. achievements
      1. group Id
        FG000
        num Subjects
        597
      2. group Id
        FG001
        num Subjects
        300
      3. group Id
        FG002
        num Subjects
        0
      type
      Vaccination 3
    5. achievements
      1. comment
        Includes 1 participant for whom completion status is unknown
        group Id
        FG000
        num Subjects
        596
      2. group Id
        FG001
        num Subjects
        300
      3. group Id
        FG002
        num Subjects
        0
      type
      COMPLETED
    6. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        6
      3. group Id
        FG002
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Base Study
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Withdrawal by Subject
    2. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        5
      type
      Lost to Follow-up
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. comment
        Not all eligible participants elected to participate in extension
        group Id
        FG002
        num Subjects
        102
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        102
      type
      Vaccination 4
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        99
      type
      Vaccination 5
    4. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. comment
        1 participant received 6th vaccination outside the context of study but completed the study.
        group Id
        FG002
        num Subjects
        95
      type
      Vaccination 6
    5. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        96
      type
      COMPLETED
    6. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        6
      type
      NOT COMPLETED
    title
    Extension

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice